A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials (Q4665957): Difference between revisions
From MaRDI portal
Changed an Item |
Created claim: Wikidata QID (P12): Q52245488, #quickstatements; #temporary_batch_1711486624475 |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.2307/2534012 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2315885933 / rank | |||
Normal rank | |||
| Property / Wikidata QID | |||
| Property / Wikidata QID: Q52245488 / rank | |||
Normal rank | |||
Latest revision as of 23:57, 26 March 2024
scientific article; zbMATH DE number 2155396
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials |
scientific article; zbMATH DE number 2155396 |
Statements
A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials (English)
0 references
11 April 2005
0 references
Bayesian inference
0 references
clinical trial
0 references
dose-finding studies
0 references
phase I trial
0 references
phase II trial
0 references
safety monitoring
0 references
